Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
All Cosmos Bio-Tech HoldingTPE:4148 -0.31%84 Debt-to-Equity is 0.10 as of Mar. 2026, which is 29% below its 10-year median of 0.14. GuruFocus rates TPE:4148 with a GF Score™ of 84/100 and a GF Value™ of NT$45.35 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 230 Agriculture companies, All Cosmos Bio-Tech Holding ranks better than 81.3% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for All Cosmos Bio-Tech Holding's Debt-to-Equity or its related term are showing as below:
TPE:4148'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.14 Max: 0.59
Current: 0.1
During the past 13 years, the highest Debt-to-Equity Ratio of All Cosmos Bio-Tech Holding was 0.59. The lowest was 0.00. And the median was 0.14.
TPE:4148's Debt-to-Equity is ranked better than 81.3% of 230
companies
in the Agriculture industry
Industry Median: 0.365
vs TPE:4148: 0.10
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
All Cosmos Bio-Tech Holding Debt-to-Equity Related Terms
All Cosmos Bio-Tech Holding Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4148 vs CTVA, CF, MOS: Debt-to-Equity Comparison
For the Agricultural Inputs subindustry, All Cosmos Bio-Tech Holding's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
All Cosmos Bio-Tech Holding Debt-to-Equity vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, All Cosmos Bio-Tech Holding's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where All Cosmos Bio-Tech Holding's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
All Cosmos Bio-Tech Holding (TPE:4148) has a Debt-to-Equity of 0.10 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on All Cosmos Bio-Tech Holding and its competitors. This is 29% below median its historical median of 0.14. According to the industry distribution chart, All Cosmos Bio-Tech Holding ranks #43 out of 230 companies in the Agriculture industry, placing it in the top 18.7%.
Is All Cosmos Bio-Tech Holding's Debt-to-Equity too high?
All Cosmos Bio-Tech Holding's current Debt-to-Equity of 0.10 is 29% below median its 10-year median of 0.14. The Agriculture industry median Debt-to-Equity is 0.37. All Cosmos Bio-Tech Holding's value of 0.10 is 72.6% below this industry median. Based on the distribution chart, All Cosmos Bio-Tech Holding ranks #43 out of 230 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, All Cosmos Bio-Tech Holding has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does All Cosmos Bio-Tech Holding's Debt-to-Equity compare to CTVA and CF?
According to the Agriculture industry distribution chart, All Cosmos Bio-Tech Holding ranks #43 out of 230 companies for Debt-to-Equity. This places All Cosmos Bio-Tech Holding in the top 19% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.37. All Cosmos Bio-Tech Holding's value of 0.10 is 72.6% below this benchmark. While the company's 10-year median is 0.14 vs. the industry median of 0.37, All Cosmos Bio-Tech Holding has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for an Agriculture company?
The median Debt-to-Equity among Agriculture companies is 0.37, based on 230 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. All Cosmos Bio-Tech Holding's current Debt-to-Equity of 0.10 is 72.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on All Cosmos Bio-Tech Holding and its competitors. For the Agriculture industry, the median Debt-to-Equity is 0.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. All Cosmos Bio-Tech Holding's current Debt-to-Equity is 0.10, which is 29% below median its own 10-year median of 0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is All Cosmos Bio-Tech Holding stock overvalued right now?
Based on GuruFocus' analysis, All Cosmos Bio-Tech Holding (TPE:4148) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$45.35, compared to a current price of NT$31.90 — trading 29.7% below its estimated fair value. The current Debt-to-Equity is 0.10, which is 29% below median its 10-year median of 0.14 and 72.6% below the Agriculture industry median of 0.37. All Cosmos Bio-Tech Holding's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For All Cosmos Bio-Tech Holding (TPE:4148), the current Debt-to-Equity is 0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is All Cosmos Bio-Tech Holding (TPE:4148) Overvalued in 2026?
Based on GuruFocus' analysis, All Cosmos Bio-Tech Holding stock appears to be undervalued.
The current stock price of NT$31.90 is trading 29.7% below its estimated GF Value™ of NT$45.35.
GuruFocus considers All Cosmos Bio-Tech Holding to be Significantly Undervalued.
Key valuation signals for TPE:4148:
Debt-to-Equity: 0.10 (29% below median its 10-year median of 0.14)
GF Value™: NT$45.35 vs. price of NT$31.90 (29.7% below fair value)
Industry Position: 72.6% below the Agriculture median (#43 of 230)
No single metric tells the full story. See the TPE:4148 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
All Cosmos Bio-Tech Holding Corp is involved in a wide range of industries, mainly divided into 4 focused areas, including agriculture, waste reutilization, health care and pharmaceutical, and research and development of microbials. The group's reportable segments are All Cosmos Industries Sdn. Bhd. (ACI), Sabah Softwoods Hybrid Fertiliser Sdn. Bhd. (SSHF) and others. The majority of its revenue is generated from the ACI segment, which operates as a manufacturer and marketer of Bio-Organic and Bio-Chemical fertilizers. It offers various organic, bio-chemical, bio-control, and chemical fertilizers. Geographically, the group derives maximum revenue from Malaysia and the rest from other markets.
84GF Score
Get the complete analysis for TPE:4148
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4148 has been successfully added to your 
